Venkata Lakshmana R. Chunduru
Directeur/Membre du Conseil chez LAURUS LABS LIMITED
Fortune : 73 M $ au 30/04/2024
Profil
Venkata Lakshmana R.
Chunduru is currently an Executive Director at Laurus Labs Ltd.
and a Director at Sriam Labs Pvt Ltd.
He graduated and earned a doctorate degree from Andhra University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LAURUS LABS LTD.
2,50% | 30/09/2023 | 13 450 145 ( 2,50% ) | 73 M $ | 30/04/2024 |
Postes actifs de Venkata Lakshmana R. Chunduru
| Sociétés | Poste | Début |
|---|---|---|
| LAURUS LABS LIMITED | Directeur/Membre du Conseil | 08/03/2018 |
Sriam Labs Pvt Ltd.
 Sriam Labs Pvt Ltd. Pharmaceuticals: MajorHealth Technology Sriam Labs Pvt Ltd. manufactures and supplies pharmaceutical products. Its product portfolio includes biperidine hydrochloride, biperidine base, flavoxate hydrochloride, famciclovir, labetalol hydrochloride, memantine hydrochloride, moxifloxacin hydrochloride and trimipramine. The company was founded in 2002 and is headquartered in Hyderabad, India. | Directeur/Membre du Conseil | 25/07/2014 |
Formation de Venkata Lakshmana R. Chunduru
| Andhra University | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LAURUS LABS LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Sriam Labs Pvt Ltd.
Sriam Labs Pvt Ltd. Pharmaceuticals: MajorHealth Technology Sriam Labs Pvt Ltd. manufactures and supplies pharmaceutical products. Its product portfolio includes biperidine hydrochloride, biperidine base, flavoxate hydrochloride, famciclovir, labetalol hydrochloride, memantine hydrochloride, moxifloxacin hydrochloride and trimipramine. The company was founded in 2002 and is headquartered in Hyderabad, India. | Health Technology |